Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Chubb
Covington
Federal Trade Commission
QuintilesIMS
Moodys
Farmers Insurance
Argus Health
Medtronic
Queensland Health

Generated: August 21, 2017

DrugPatentWatch Database Preview

TIMOPTIC Drug Profile

« Back to Dashboard

What is the patent landscape for Timoptic, and when can generic versions of Timoptic launch?

Timoptic is a drug marketed by Aton and Valeant Pharms Llc and is included in three NDAs.

The generic ingredient in TIMOPTIC is timolol maleate. There are fifteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the timolol maleate profile page.

Summary for Tradename: TIMOPTIC

Patents:0
Applicants:2
NDAs:3
Suppliers / Packagers: see list2
Bulk Api Vendors: see list56
Clinical Trials: see list16
Patent Applications: see list5,704
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TIMOPTIC at DailyMed

Pharmacology for Tradename: TIMOPTIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aton
TIMOPTIC
timolol maleate
SOLUTION/DROPS;OPHTHALMIC018086-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Aton
TIMOPTIC IN OCUDOSE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC019463-002Nov 5, 1986RXYesYes► Subscribe► Subscribe► Subscribe
Aton
TIMOPTIC
timolol maleate
SOLUTION/DROPS;OPHTHALMIC018086-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Aton
TIMOPTIC IN OCUDOSE
timolol maleate
SOLUTION/DROPS;OPHTHALMIC019463-001Nov 5, 1986RXYesYes► Subscribe► Subscribe► Subscribe
Valeant Pharms Llc
TIMOPTIC-XE
timolol maleate
SOLUTION, GEL FORMING/DROPS;OPHTHALMIC020330-002Nov 4, 1993ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TIMOPTIC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aton
TIMOPTIC
timolol maleate
SOLUTION/DROPS;OPHTHALMIC018086-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Aton
TIMOPTIC
timolol maleate
SOLUTION/DROPS;OPHTHALMIC018086-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Aton
TIMOPTIC
timolol maleate
SOLUTION/DROPS;OPHTHALMIC018086-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Aton
TIMOPTIC
timolol maleate
SOLUTION/DROPS;OPHTHALMIC018086-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Daiichi Sankyo
McKinsey
Queensland Health
Chubb
Medtronic
Dow
Cantor Fitzgerald
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot